The STEP trials for semaglutide 2.4 mg (Wegovy) showed: Average weight loss of approximately 15% of body weight over 68 weeks One-third of participants lost 20% or more of body weight Significant reductions in waist circumference, blood pressure, and cardiovascular risk markers The SURMOUNT trials for tirzepatide (Zepbound) showed even more impressive results: Average weight loss of 20-25% at the highest dose (15 mg) over 72 weeks More than half of participants lost 20% or more of body weight Significant improvements in type 2 diabetes markers, blood pressure, and lipid profiles The head-to-head comparison is clear
If you are using hormonal contraception, tirzepatide can occasionally reduce its effectiveness due to changes in gastrointestinal absorption, so alert your prescriber about both medications
Sleep and stress Cortisol, the primary stress hormone, promotes fat storage and increases appetite
Turn the bottle upside down just before feeding
At Hawaii Wellness Clinic in , our physician-supervised Semaglutide GLP-1 Program delivers this breakthrough treatment within a fully personalized, medically monitored framework designed to help you lose weight safely, steadily, and for the long term
Start with the online intake